FDA will no longer recommend Covid vaccine boosters for healthy Americans under 65

By James Lynch | National Review

Federal regulators announced Tuesday a new regulatory policy for Covid-19 approvals designed to limit vaccine approvals to older Americans and those at serious risk from the virus.

The FDA’s new policy will make seasonal Covid-19 vaccines available to the elderly and those with health conditions that put them at a greater risk of infection, but not for young adults and children who otherwise face little risk of suffering from debilitating Covid-19 symptoms.

Food and Drug Administration Commissioner Dr. Marty Makary and Center for Biologics Evaluation and Research director Dr. Vinay Prasad unveiled the policy in a new paper published by the New England Journal of Medicine.

READ THE FULL STORY AT THE NATIONAL REVIEW